http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10042743

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase III|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 1711
issn 0315-162X
1499-2752
issueIdentifier 8
pageRange 1703-1711
publicationName The Journal of Rheumatology
startingPage 1703
bibliographicCitation Sundy JS, Schumacher HR, Kivitz A, Weinstein SP, Wu R, King-Davis S, Evans RR. Rilonacept for gout flare prevention in patients receiving uric acid-lowering therapy: results of RESURGE, a phase III, international safety study. J Rheumatol. 2014 Aug;41(8):1703–11. doi: 10.3899/jrheum.131226. PMID: 25028379.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_151ef6f1a69841b206a5fa58c16fe33a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_234eead6787eee956d54d538b4fadac7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bacecece45345a32aca2c461d4c96309
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b091dc9f010dfd63e1815cd889e9ba4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9cf531008b4c0bdbd9409ff5f3aa04d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d5e6457ef4d0c5ead19ed7ca78b6d9af
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0df3b199983b2b044ade0d77deb59948
date 2014-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.3899/jrheum.131226
https://pubmed.ncbi.nlm.nih.gov/25028379
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5243
https://portal.issn.org/resource/ISSN/0315-162X
https://portal.issn.org/resource/ISSN/1499-2752
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Rilonacept for Gout Flare Prevention in Patients Receiving Uric Acid-lowering Therapy: Results of RESURGE, a Phase III, International Safety Study
discusses http://id.nlm.nih.gov/mesh/M0022340
http://id.nlm.nih.gov/mesh/M0524772
http://id.nlm.nih.gov/mesh/M0027742
http://id.nlm.nih.gov/mesh/M0009558
http://id.nlm.nih.gov/mesh/M0018640
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D011993Q000627
http://id.nlm.nih.gov/mesh/D011993Q000009
http://id.nlm.nih.gov/mesh/D006074Q000627
http://id.nlm.nih.gov/mesh/D006073Q000517
http://id.nlm.nih.gov/mesh/D018501Q000627
http://id.nlm.nih.gov/mesh/D018501Q000009
http://id.nlm.nih.gov/mesh/D014527Q000097
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D006073Q000188
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D006073Q000097
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D011993Q000008
http://id.nlm.nih.gov/mesh/D018501Q000008
http://id.nlm.nih.gov/mesh/D038622
http://id.nlm.nih.gov/mesh/D053208
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D007279
http://id.nlm.nih.gov/mesh/D017063
http://id.nlm.nih.gov/mesh/D004359
http://id.nlm.nih.gov/mesh/D055815
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D004311
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7635
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6642
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10298
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1175
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9505
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7872
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11418

Total number of triples: 70.